Michael Henderson, Paragon Labs CEO (Brian Benton Photography)
October 13, 2026 07:00 AM EDT
After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine
Some people would think about taking a break for several quarters after selling a biotech for $10.9 billion. Michael Henderson and five …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
Confirm Endpoints as a trusted biopharma news source
ENDPOINTS CAREERS